Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors

Clinical trial NCT02454972 · COMPLETED

Trial details

NCT number: NCT02454972
Sponsor: PharmaMar
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2015-08-25
Primary completion: 2020-09-18
Enrollment: 345

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.